Close
Help





JOURNAL

Biomarker Insights

Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs

Submit a Paper


Biomarker Insights 2015:Suppl. 4 59-72

Review

Published on 16 Feb 2016

DOI: 10.4137/BMI.S29514


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Biomarker Insights

Abstract

This review discusses biomarkers that are being researched for their usefulness to phenotype chronic inflammatory lung diseases that cause remodeling of the lung’s architecture. The review focuses on asthma, chronic obstructive pulmonary disease (COPD), and pulmonary hypertension. Biomarkers of environmental exposure and specific classes of biomarkers (noncoding RNA, metabolism, vitamin, coagulation, and microbiome related) are also discussed. Examples of biomarkers that are in clinical use, biomarkers that are under development, and biomarkers that are still in the research phase are discussed. We chose to present examples of the research in biomarker development by diseases, because asthma, COPD, and pulmonary hypertension are distinct entities, although they clearly share processes of inflammation and remodeling.



Downloads

PDF  (622.35 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML


Video Abstract




Quick Links


New article and journal news notification services